The novel 13 S ,14 S ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A 4 hydrolase (LTA 4 H), and shifts macrophage phenotype
Open accessThe DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
Maresins are produced by macrophages from docosahexaenoic acid (DHA) and exert potent proresolving and tissue homeostatic actions. Maresin 1 (MaR1; 7 R ,14 S ‐dihydroxy‐docosa‐4 Z ,8 E ,10 E ,12 Z ,16 Z ,19 Z ‐hexaenoic acid) is the first identified maresin. Here, we investigate formation, stereochemistry, and precursor role of 13,14‐epoxy‐docosahexaenoic acid, an intermediate in MaR1 biosynthesis. The 14‐lipoxygenation of DHA by human macrophage 12‐lipoxygenase (hm12‐LOX) gave 14‐hydro(peroxy)‐docosahexaenoic acid (14‐HpDHA), as well as several dihydroxy‐docosahexaenoic acids, implicating an epoxide intermediate formation by this enzyme. Using a stereo‐controlled synthesis, enantiomerically pure 13 S ,14 S ‐epoxy‐docosa‐4 Z ,7 Z ,9 E ,11 E ,16 Z ,19 Z ‐hexaenoic acid (13 S ,14 S ‐epoxy‐DHA) was prepared, and its stereochemistry was confirmed by NMR spectroscopy. When this 13 S ,14 S ‐epoxide was incubated with human macrophages, it was converted to MaR1. The synthetic 13 S ,14 S ‐epoxide inhibited leukotriene B 4 (LTB 4 ) formation by human leukotriene A 4 hydrolase (LTA 4 H) ~40% ( P <0.05) to a similar extent as LTA4 (~50%, P <0.05) but was not converted to MaR1 by this enzyme. 1 3S ,14 S ‐epoxy‐DHA also reduced (~60%; P <0.05) arachidonic acid conversion by hm12‐LOX and promoted conversion of M1 macrophages to M2 phenotype, which produced more MaR1 from the epoxide than M1. Together, these findings establish the biosynthesis of the 13 S ,14 S ‐epoxide, its absolute stereochemistry, its precursor role in MaR1 biosynthesis, and its own intrinsic bioactivity. Given its actions and role in MaR1 biosynthesis, this epoxide is now termed 13,14‐epoxy‐maresin (13,14‐eMaR) and exhibits new mechanisms in resolution of inflammation in its ability to inhibit proinflammatory mediator production by LTA4 hydrolase and to block arachidonate conversion by human 12‐LOX rather than merely terminating phagocyte involvement.—Dalli, J., Zhu, M., Vlasenko, N. A., Deng, B., Haeggström, J. Z., Petasis, N. A., Serhan, C. N. The novel 13 S ,14 S ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H) and shifts macrophage phenotype. FASEB J. 27, 2573–2583 (2013). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“At least some of these lipid metabolites are produced by macrophages (101) and also signal to macrophages to reduce inflammatory and fibrogenic gene expression (102).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resolvins and protectins in inflammation resolution
Serhan, C. N., & Petasis, N. A. (2011) · Chemical Reviews · doi:10.1021/cr100396c · Cited by 996
Self-citationMaresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions
Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., & Spite, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081880 · Cited by 908 · cited 10×
“In the biosynthesis of MaR1, DHA undergoes 14S-lipoxygenation to give 14-HpDHA that is converted to 13S,14S-epoxy-DHA, a proposed intermediate that is then further transformed to MaR1 (8).”
BackgroundMethodInfluentialSelf-citationResolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., & Serhan, C. N. (2009) · Nature · doi:10.1038/nature08541 · Cited by 695 · cited 1×
“The ability to identify resolvins revealed their remarkable protective actions, including their ability to enhance immune vigilance (23) and to stimulate host immune responses, lowering antibiotic requirements during infection (24).”
BackgroundSelf-citationInfection regulates pro-resolving mediators that lower antibiotic requirements
Chiang, N., Fredman, G., Bäckhed, F., Oh, S. F., Vickery, T., Schmidt, B. A., & Serhan, C. N. (2012) · Nature · doi:10.1038/nature11042 · Cited by 664
Self-citationMacrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain
Serhan, C. N., Dalli, J., Karamnov, S., Choi, A., Park, C., Xu, Z., Ji, R., Zhu, M., & Petasis, N. A. (2012) · The FASEB Journal · doi:10.1096/fj.11-201442 · Cited by 595 · cited 7×
“We next determined the identity of these DHA-derived products by assessing their respective MS-MS spectra and matching with synthetic and/or authentic standards (11).”
BackgroundInfluentialSelf-citationShimizu, T. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145616 · Cited by 576 · cited 1×
“3 min that corresponded to the known nonenzymatic hydrolysis products of LTA4 (3, 4) with the major peak at TR 5.”
Backgroundn–3 Fatty Acids in Cardiovascular Disease
De Caterina, R. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1008153 · Cited by 568
Dalli, J., & Serhan, C. N. (2012) · Blood · doi:10.1182/blood-2012-04-423525 · Cited by 547
Self-citationFatty acids and inflammation: The cutting edge between food and pharma
Calder, P. C. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.085 · Cited by 516 · cited 1×
“It is now well appreciated that -3 fatty acids exert a positive bearing on several important aspects of cardiovascular disease (30, 31).”
BackgroundMetabolic oxidation regulates embryonic stem cell differentiation
Yanes, O., Clark, J., Wong, D. M., Patti, G. J., Sánchez-Ruiz, A., Benton, H. P., Trauger, S. A., Desponts, C., Ding, S., & Siuzdak, G. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.364 · Cited by 506
Titos, E., Rius, B., González-Périz, A., López-Vicario, C., Morán-Salvador, E., Martínez-Clemente, M., Arroyo, V., & Clària, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100225 · Cited by 412 · cited 1×
“Recent results indicate that DHA and DHA-derived proresolving mediators, including RvD1, can stimulate a switch in macrophage phenotype from proinflammatory to a proresolving M2-like phenotype (17, 18).”
BackgroundMonocyte trafficking in acute and chronic inflammation
Ingersoll, M. A., Platt, A. M., Potteaux, S., & Randolph, G. J. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.05.001 · Cited by 346 · cited 1×
“In this context, there are two broad categories: M1 macrophages or classical macrophages are considered as proinflammatory, while M2 macrophages are linked with the reestablishment of homeostasis, wound healing, and tissue regeneration (5, 7, 16).”
BackgroundResolvin D Series and Protectin D1 Mitigate Acute Kidney Injury
Duffield, J. S., Hong, S., Vaidya, V. S., Lu, Y., Fredman, G., Serhan, C. N., & Bonventre, J. V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5902 · Cited by 334 · cited 1×
“Together, these findings underscore a role for macrophage-derived proresolving mediators in potentially preventing further tissue damage and/or organ fibrosis in disease (10, 19).”
BackgroundSelf-citationHellmann, J., Tang, Y., Kosuri, M., Bhatnagar, A., & Spite, M. (2011) · The FASEB Journal · doi:10.1096/fj.10-178657 · Cited by 302 · cited 1×
“Recent results indicate that DHA and DHA-derived proresolving mediators, including RvD1, can stimulate a switch in macrophage phenotype from proinflammatory to a proresolving M2-like phenotype (17, 18).”
BackgroundTranscriptomic analyses of murine resolution-phase macrophages
Stables, M. J., Shah, S., Camon, E. B., Lovering, R. C., Newson, J., Bystrom, J., Farrow, S., & Gilroy, D. W. (2011) · Blood · doi:10.1182/blood-2011-04-345330 · Cited by 291 · cited 1×
“phage subtype, referred to as resolution-phase macrophages, was identified in resolving exudates, with these macrophages possessing characteristics of both M1 and M2 cells (5, 6), and each human subpopulation expresses 12-LOX.”
BackgroundEnzyme with dual lipoxygenase activities catalyzes leukotriene A4 synthesis from arachidonic acid.
Shimizu, T., Rådmark, O., & Samuelsson, B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.3.689 · Cited by 290
Oh, S. F., Pillai, P. S., Recchiuti, A., Yang, R., & Serhan, C. N. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42545 · Cited by 290 · cited 1×
“E-series resolvins (26), we assessed conversion of 13S,14S-epoxy-DHA with LTA4H, which did not result in MaR1 production (Fig.”
MethodSelf-citationAyoub, S. S. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9781139195737 · Cited by 214
Giera, M., Ioan-Facsinay, A., Toes, R., Gao, F., Dalli, J., Deelder, A. M., Serhan, C. N., & Mayboroda, O. A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.011 · Cited by 208 · cited 3×
“synovial fluids from patients with arthritis (10).”
BackgroundSelf-citationAriel, A., & Serhan, C. N. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00004 · Cited by 183 · cited 2×
“In this context, there are two broad categories: M1 macrophages or classical macrophages are considered as proinflammatory, while M2 macrophages are linked with the reestablishment of homeostasis, wound healing, and tissue regeneration (5, 7, 16).”
BackgroundSelf-citationZhang, M. J., & Spite, M. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150726 · Cited by 171 · cited 1×
“In this context, there are two broad categories: M1 macrophages or classical macrophages are considered as proinflammatory, while M2 macrophages are linked with the reestablishment of homeostasis, wound healing, and tissue regeneration (5, 7, 16).”
BackgroundRole of Basic Science in the Development of New Medicines: Examples from the Eicosanoid Field
Samuelsson, B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.x112.351437 · Cited by 156 · cited 3×
“LM biosynthesis involves multiple enzyme-regulated steps that determine the specific stereochemistry of each member of these local mediator families (2, 3).”
BackgroundCloning of the cDNA for human 12-lipoxygenase.
Izumi, T., Hoshiko, S., Rådmark, O., & Samuelsson, B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7477 · Cited by 115 · cited 1×
“The RNA sequence (Supplemental Table S1) and deduced protein matched that reported previously (14).”
ResultMetabolomics‐Lipidomics of Eicosanoids and Docosanoids Generated by Phagocytes
Yang, R., Chiang, N., Oh, S. F., & Serhan, C. N. (2011) · Current Protocols in Immunology · doi:10.1002/0471142735.im1426s95 · Cited by 104 · cited 1×
“Identification was conducted using published criteria where a minimum of 6 diagnostic ions were employed (12).”
MethodSelf-citationLeukotriene A4 hydrolase in the human lung. Inactivation of the enzyme with leukotriene A4 isomers.
Ohishi, N., Izumi, T., Minami, M., Kitamura, S., Seyama, Y., Ohkawa, S., Terao, S., Yotsumoto, H., Takaku, F., & Shimizu, T. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61098-1 · Cited by 94 · cited 1×
“Since LTA4 is known to inactivate LTA4H, preventing the conversion of LTA4 to LTB4 (15), we next investigated whether 13S,14S-epoxy-DHA also exerted inhibi-”
BackgroundLeukotriene A4Hydrolase/Aminopeptidase
Rudberg, P. C., Tholander, F., Thunnissen, M. M. G. M., & Haeggström, J. Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106577200 · Cited by 79 · cited 3×
“Since LTA4H catalyzes LTA4 conversion to LTB4 (13) and is involved in the conversion of EPA to RvE1 in the”
BackgroundMethodSelf-citationLu, Y., Tian, H., & Hong, S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m000059 · Cited by 66 · cited 1×
“Along these lines, the 14-HpDHA intermediate can also undergo another double dioxygenation at the penultimate carbon ( -1) to give the 14S,21R-dihydroxydocosa-4Z,7Z,10Z,12E,16Z,19Z-hexaenoic acid (20).”
BackgroundTian, H., Lu, Y., Shah, S. P., & Hong, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100388 · Cited by 58 · cited 1×
“ing in diabetes models and following renal ischemia reperfusion injury by restoring mesenchymal stem cell function (21, 22).”
BackgroundLeukotriene A4 hydrolase: mapping of a henicosapeptide involved in mechanism-based inactivation.
Mueller, M. J., Wetterholm, A., Blomster, M., Jörnvall, H., Samuelsson, B., & Haeggström, J. Z. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8383 · Cited by 56 · cited 1×
“This is a regulatory mechanism that the 13S,14S-epoxide intermediate shares with LTA4 (29) and that would be operative in the conversion of DHA to MaR1.”
BackgroundSelf-citationLeukocytes as Secretory Organs of Inflammation
Weissmann, G. (1978) · Hospital Practice · doi:10.1080/21548331.1978.11707397 · Cited by 55
Tian, H., Lü, Y., Shah, S. P., Wang, Q., & Hong, S. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0220 · Cited by 39 · cited 1×
“ing in diabetes models and following renal ischemia reperfusion injury by restoring mesenchymal stem cell function (21, 22).”
Background
Cited by
Pro-resolving lipid mediators are leads for resolution physiology
Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041
Self-citationInflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
Self-citationProresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
Buckley, C. D., Gilroy, D. W., & Serhan, C. N. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.009 · Cited by 807
Self-citationThe resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
Serhan, C. N., Chiang, N., & Dalli, J. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.004 · Cited by 583
Self-citation
Metadata
- Authors
- Dalli, J., Zhu, M., Vlasenko, N. A., Deng, B., Haeggström, J. Z., Petasis, N. A., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Southern California (US)
- Karolinska Institutet (SE)
- Corresponding author
- Petasis, Nicos A.
- Serhan, Charles N.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2013-03-15
- Volume
- 27
- Issue
- 7
- Pages
- 2573-2583
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3688739
- OpenAlex
- W2100994932
- Cited by
- 283
- References
- 32
- Citations by year
- 2026: 20 · 2025: 14 · 2024: 13 · 2023: 25 · 2022: 23 · 2021: 23 · 2020: 30 · 2019: 19 · 2018: 28 · 2017: 26 · 2016: 18 · 2015: 20 · 2014: 20 · 2013: 4
- FWCI
- 19.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (P01GM095467)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- maresin 1, epoxyeicosatrienoic acids, docosahexaenoic acid, 12-lipoxygenase, leukotriene A4 hydrolase, macrophage phenotype, leukotriene B4, specialized pro-resolving mediators, eicosanoid biosynthesis
- MeSH terms
- Arachidonate 12-Lipoxygenase, Cells, Cultured, Docosahexaenoic Acids, Epoxide Hydrolases, Humans, Leukotriene B4, Macrophages, Models, Chemical, Magnetic Resonance Spectroscopy, Molecular Structure, Arachidonic Acid, Biocatalysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.